ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,825Medicare Part D Prescriptions Filled, Including Refills

Rank: 26 out of 384

$483K Total Retail Price of All Prescriptions

Rank: 67 out of 384

676 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
2% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 676 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

3% of this provider’s 13,594 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$29 was the average price of a prescription from this provider, compared to $45 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
ENALAPRIL MALEATE 843 658 1 6
SIMVASTATIN 754 615 2 1
FUROSEMIDE 710 602 3 17
METFORMIN HCL 651 518 4 2
AMLODIPINE BESYLATE 623 526 5 3
RANITIDINE HCL 577 496 6 7
GABAPENTIN 552 433 7 4
CARVEDILOL 485 412 8 23
HYDROCHLOROTHIAZIDE 466 373 9 16
ATENOLOL 454 385 10 12
LOSARTAN-HYDROCHLOROTHIAZIDE 378 288 11 10
LEVOTHYROXINE SODIUM 365 333 12 11
METOPROLOL TARTRATE 297 252 13 15
ISOSORBIDE MONONITRATE ER 294 265 14 28
GLIPIZIDE 293 265 15 27
HUMULIN N 278 226 16 57
SURE COMFORT 270 209 17 96
INSULIN SYRINGE 263 190 18 46
HUMULIN 70-30 239 215 19 47
OMEPRAZOLE 234 202 20 8
LOSARTAN POTASSIUM 220 203 21 5
DOXAZOSIN MESYLATE 202 165 22 29
LEVOXYL 193 155 23 44
VERAPAMIL ER 179 146 24 41
DIGOXIN 177 152 25 49
TRAMADOL HCL 170 141 26 40
GLIMEPIRIDE 156 144 27 18
CAPTOPRIL 156 115 27 72
CILOSTAZOL 147 136 29 70
ASPIRIN EC 144 134 30 31
ENALAPRIL-HYDROCHLOROTHIAZIDE 140 103 31 134
FAMOTIDINE 137 105 32 35
MELOXICAM 134 122 33 85
AMITRIPTYLINE HCL 132 116 R 34 75
GEMFIBROZIL 126 86 35 74
NAPROXEN SODIUM 125 92 36 164
TRAMADOL HCL-ACETAMINOPHEN 122 76 37 13
FINASTERIDE 122 118 37 62
SYNTHROID 121 97 39 9
CIPROFLOXACIN HCL 116 95 40 50
WARFARIN SODIUM 112 88 41 48
ALENDRONATE SODIUM 110 105 42 20
DIPYRIDAMOLE 101 91 R 43 97
TAMSULOSIN HCL 98 92 44 25
CLONIDINE HCL 90 61 45 84
MECLIZINE HCL 88 83 46 73
LATANOPROST 81 78 47 76
BETAMETHASONE DIPROPIONATE 81 49 47 175
LANTUS 78 39 49 42
DEXAMETHASONE 76 61 50 117
ISOSORBIDE DINITRATE 75 74 51 118
SINGULAIR 74 42 52 63
ALLOPURINOL 73 55 53 94
ASPIRIN 73 50 53 304
LISINOPRIL 66 53 55 14
GLYBURIDE 65 60 R 56 82
PROVENTIL HFA 65 42 56 156
CLOPIDOGREL 62 44 58 30
HUMALOG MIX 50-50 62 25 58 261
AMLODIPINE BESYLATE-BENAZEPRIL 61 57 60 43
THEOPHYLLINE ANHYDROUS 60 41 61 159
SERTRALINE HCL 57 45 62 26
PHENYTOIN SODIUM EXTENDED 56 43 63 269
GLYBURIDE-METFORMIN HCL 55 54 R 64 64
IBUPROFEN 53 33 65 224
LACTULOSE 51 50 66 270
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 13, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.